Stem Cell Network (SCN)
2023-2025 Research Funding Competition
For More Information
A technical briefing will be held via Zoom on August 17 at 1 pm ET. Interested applicants are encouraged to register here.
The Stem Cell Network (SCN) announced the second and final of two national research funding competitions planned for SCN’s 2022-2025 funding cycle. This new competition will support world-class, translational, regenerative medicine research, across the research continuum for the 2023-2025 period to facilitate health, social and economic benefits for Canadians.
The five funding programs available are:
- Impact Awards: SCN will provide up to $250,000 to support proof-of-principle experiments, including novel therapeutic or technical approach development that will drive regenerative medicine therapies forward.
- Impact Awards: ELSI Stream: SCN will provide up to $200,000 to support knowledge creation and translation of regenerative medicine research for targeted stakeholders and/or users.
- Accelerating Clinical Translation Awards: SCN will provide up to $600,000 to support multi-disciplinary research that is moving towards the clinic within five years; or is addressing a key research question associated with an ongoing clinical trial.
- Clinical Trial Awards: SCN will provide up to $750,000 to support early-stage clinical trial projects with high translational potential.
- Fueling Biotechnology Partnerships Awards: SCN will provide up to $400,000 to support academic partnerships with emerging Canadian regenerative medicine biotechnology companies to bring innovative technologies or therapies to the clinic or market.
For program information and details on how to apply, visit the Research Funding Opportunities section on the Stem Cell Network website.
Please see the program-specific eligibility criteria in each program's Guidelines Document found on the 2023-2025 Research Funding Competition's website.
Indirect costs and PI salaries are not eligible for funding.
The competition will open on Thursday, September 1, 2022, and supports research activities during the 2023–2025 time period.
Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.
If College-level review is required, your College will communicate its earlier internal deadlines.
Letter of Intent (LOI) submissions open for all funding programs.
Letter of intent (LOI) submission deadline for all funding programs.
Full application submission deadline.
How to Apply
A Letter of Intent (LOI) submission is mandatory for all programs. LOIs will be used to identify peer review requirements, gauge the level of interest in SCN’s programs, and ensure projects fall within SCN’s regenerative medicine mandate. Eligible LOIs will be invited to submit a full application on Tuesday, September 27, 2022. LOI and full application-related questions should be addressed to Jon Draper (firstname.lastname@example.org).
SCN has modernized its funding application process and all applications must be submitted via an online application process hosted through the ProposalCentral application portal. All investigators (Lead and Co-investigators) on a team should register and open an account on ProposalCentral prior to initiating an application. ProposalCentral accounts are not required for collaborators or highly qualified personnel (HQP; e.g. graduate students, post-doctoral fellows, technicians or research associates).
The Letter of Intent Instructions for ProposalCentral should be consulted prior to application.